Literature DB >> 14936179

Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium.

R L JOHNSON, E D FREIS, H W SCHNAPER.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use

Mesh：

Substances：

Year:  1952        PMID： 14936179     DOI： 10.1161/01.cir.5.6.833

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  [Comparative clinical studies on the effect of hydrazinophthalazine and Rauwolfia alkaloid reserpin on the blood pressure].

Authors:  K KUHNS; R DJURANOVIC; C GEHRS; K KOPPEN
Journal:  Klin Wochenschr       Date:  1954-10-01

2.  Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (apresoline) in hypertensive subjects.

Authors:  D H STEIN; H H HECHT
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

3.  A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.

Authors:  E S ORGAIN; C L RAST; H A SIEBER
Journal:  Trans Am Clin Climatol Assoc       Date:  1953

4.  The clinical evaluation and management of hypertension.

Authors:  A V GOODYER; E ROSENTHAL; C A JAEGER
Journal:  Yale J Biol Med       Date:  1955-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.